Antonio Sica

Università degli Studi del Piemonte Orientale “Amedeo Avogadro” — Italy

Immunology and Microbiology · Life Sciences

81h-index60.2kcitations297works1.12yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Immune cells in cancer(141), Immune Cell Function and Interaction(53), Cancer Immunotherapy and Biomarkers(44), Immune Response and Inflammation(42), Immunotherapy and Immune Responses(40)

Publications297 total

Gasotransmitters bridging tumor biology and immunity: from pathophysiological insights to therapeutic potential
Frontiers in Immunology·2026Open Access
Myeloid metabolism and its role in immunotherapy of cancer
Journal for ImmunoTherapy of Cancer·2025· 1 citedOpen Access
787 RORγ bridges cancer-driven lipid dysmetabolism and myeloid immunosuppression
Regular and Young Investigator Award Abstracts·2025Open Access
1927P Tracking myeloid cells variation in peripheral blood in advanced lung cancer: Prognostic and predictive role during ICIs
Annals of Oncology·2025
Figure S7 from RORγ Bridges Cancer-Driven Lipid Dysmetabolism and Myeloid Immunosuppression
2025Open Access
Figure S2 from RORγ Bridges Cancer-Driven Lipid Dysmetabolism and Myeloid Immunosuppression
2025Open Access
Figure S5 from RORγ Bridges Cancer-Driven Lipid Dysmetabolism and Myeloid Immunosuppression
2025Open Access
Figure S9 from RORγ Bridges Cancer-Driven Lipid Dysmetabolism and Myeloid Immunosuppression
2025Open Access
Table S5 from RORγ Bridges Cancer-Driven Lipid Dysmetabolism and Myeloid Immunosuppression
2025Open Access
Table S3 from RORγ Bridges Cancer-Driven Lipid Dysmetabolism and Myeloid Immunosuppression
2025Open Access
Figure S1 from RORγ Bridges Cancer-Driven Lipid Dysmetabolism and Myeloid Immunosuppression
2025Open Access
Figure S8 from RORγ Bridges Cancer-Driven Lipid Dysmetabolism and Myeloid Immunosuppression
2025Open Access
Data from RORγ Bridges Cancer-Driven Lipid Dysmetabolism and Myeloid Immunosuppression
2025Open Access
Table S2 from RORγ Bridges Cancer-Driven Lipid Dysmetabolism and Myeloid Immunosuppression
2025Open Access
Table S4 from RORγ Bridges Cancer-Driven Lipid Dysmetabolism and Myeloid Immunosuppression
2025Open Access
Figure S10 from RORγ Bridges Cancer-Driven Lipid Dysmetabolism and Myeloid Immunosuppression
2025Open Access
Figure S11 from RORγ Bridges Cancer-Driven Lipid Dysmetabolism and Myeloid Immunosuppression
2025Open Access
Table S1 from RORγ Bridges Cancer-Driven Lipid Dysmetabolism and Myeloid Immunosuppression
2025Open Access
Figure S6 from RORγ Bridges Cancer-Driven Lipid Dysmetabolism and Myeloid Immunosuppression
2025Open Access
Figure S3 from RORγ Bridges Cancer-Driven Lipid Dysmetabolism and Myeloid Immunosuppression
2025Open Access
page 1 of 15Next →

Frequent Co-authors

Alberto Mantovani(30), Paola Allavena(16), Massimo Locati(9), Chiara Porta(9), Subhra K. Biswas(7), Tiziana Schioppa(5), Alessandra Saccani(5), Silvano Sozzani(5), Cecília Garlanda(4), Mario P. Colombo(4), Monica Rimoldi(4), Paola Larghi(3), Maria Grazia Totaro(3), Manuela Nebuloni(3), Nadia Polentarutti(3), Annunciata Vecchi(3), Toby Lawrence(2), Gioacchino Natoli(2), Francesco Colotta(2), Vincenzo Bronte(2)